Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. After this sale, he directly holds 205,760 common shares, indicating he retains a substantial equity position.
In addition to these shares, he holds multiple option awards covering 7,500 underlying shares each from grants dated 2022 through 2026, with exercise prices ranging from $55.75 to $171.42 and expirations between 2027 and 2031. No derivative options were exercised in this filing.
National Healthcare Corp CEO Stephen Fowler Flatt reported a small insider transaction involving a bona fide gift of 26 shares of Common Stock, leaving him with 66,987 shares held directly. The filing also updates his outstanding stock option awards.
He holds options over 20,000 shares of Common Stock at an exercise price of $157.13 expiring on February 23, 2031, 12,000 shares at $90.62 expiring on February 28, 2030, 5,000 shares at $94.10 expiring on March 5, 2029, and 4,294 shares at $53.94 expiring on March 8, 2028, all held directly.
National Healthcare Corp senior vice president sells shares and reports option holdings. Sr. VP of Operations Timothy J. Shelly reported an open-market sale of 1,853 shares of National Healthcare Corp common stock at an average price of $197.2176 per share, leaving him with 1,294 directly held shares.
He also reported several outstanding stock option awards on common stock, including options covering 14,000 shares at an exercise price of $157.13 expiring in 2031, 7,333 shares at $90.62 expiring in 2030, 5,333 shares at $94.10 expiring in 2029, and 2,400 shares at $53.94 expiring in 2028.
National Healthcare Corp CEO Stephen Fowler Flatt reported routine equity compensation activity. He exercised stock options to acquire a total of 6,000 shares of common stock at exercise prices of $90.62 and $94.10 per share. The company withheld 4,492 shares to pay the option exercise price and related tax obligations, a non‑market transaction. Following these transactions, Flatt beneficially owns 67,013 shares of common stock directly. He also retains unexercised options over 20,000 shares at an exercise price of $157.13 and options over 4,294 shares at $53.94, with expirations extending to 2031.
National Healthcare Corp SVP and CFO Brian F. Kidd exercised stock options and settled related obligations in shares. He exercised derivative securities covering 4,500 shares of common stock through option exercises and had 3,134 shares of common stock withheld by the company to pay the exercise price and tax withholding obligations. These transactions are compensation-related and were granted under the 2020 Omnibus Equity Incentive Plan. Kidd also retains unexercised options linked to 14,000 and 4,147 underlying common shares at exercise prices of $157.13 and $53.94 per share, respectively.
National HealthCare Corporation entered into a Purchase and Sale Agreement for its subsidiary NHC/OP, L.P. to acquire the land, buildings, and related assets of a portfolio of five skilled nursing facilities from National Health Corporation for $50.5 million, subject to adjustments. The facilities are already managed by NHC affiliates, and existing management agreements will terminate at closing. The buyer will post a $750,000 refundable deposit during an inspection period ending by June 16, 2026, and establish a $2.0 million escrow fund for 12 months after closing to cover indemnity claims. Closing is expected in the second quarter of 2026 but depends on financing, regulatory approvals to transfer operating licenses, and other conditions, and either party may terminate if the transaction is not completed within nine months after June 1, 2026.
National HealthCare Corporation reported the results of its Annual Meeting of Shareholders held on May 7, 2026. Shareholders owning 12,216,578 shares of Common Stock were present in person or by proxy, out of 15,599,046 shares outstanding as of the March 13, 2026 record date, so a quorum was established.
Shareholders re-elected Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams as directors for three-year terms. For example, Hassan received 11,653,122 votes for, 544,934 against, and 18,522 abstentions. Shareholders also approved, on an advisory basis, the compensation of the Named Executive Officers, with 11,964,538 votes for, 233,276 against, and 18,764 abstentions.
NATIONAL HEALTHCARE CORP director Sandra Y. Trail exercised stock options and increased her direct share holdings. On May 6, 2026, she exercised options to acquire 3,140 shares of common stock at an exercise price of $55.75 per share, bringing her direct ownership to 10,640 shares.
Trail continues to hold multiple option grants. These include a 2023 grant with 4,360 options remaining, plus 2024, 2025, and 2026 grants, each tied to 7,500 underlying shares with exercise prices between $94.66 and $171.42 and expirations from 2029 through 2031. The options were granted under the company’s 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
National Healthcare Corp director William A. Adams received a grant of options to purchase 7,500 shares of common stock. The options have an exercise price of $171.42 per share, matching the closing price on May 7, 2026, and are scheduled to expire on May 6, 2030. This Form 4/A corrects a previous filing that had mistakenly reported the option price as $0.00, while the number of options and underlying shares remains 7,500.